Gene therapy biotech Capsida lays off workers after expanding AbbVie pact, adding Lilly collab
Gene therapy startup Capsida Biotherapeutics said it is laying off employees, months after unveiling two Big Pharma partnerships that brought in $125 million.
Capsida CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.